[tag=IN] □ □ □
[tag=IN] □ □ □ □
[tag=IN] □+ □ □
Nordion has tried to offer rhetorical justification of its protracted schedules for Phases 2 and 3 which Nordion estimates will require a combined six and a half years by drawing inappropriate analogies . The incidence of drug-related adverse reactions in patients during Phase 2 and 3 clinical trials was 11 % . During phase 2 and 3 trials ( studies 902 & 907 ) , Viread was given to highly treatment experienced patients . The rest of the meeting was devoted to reviewing the schedule Lynne prepared and assigning dates for phases 2 and 3 with some minor additions to phase 1 .